4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001062993-25-004809
CEO and Chairman sold 219,569 shares at an average $7.29 ($1,600,417)
- CEO and Chairman acquired 602,117 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
ROBINS CHAD M · CEO and Chairman
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-04 | Grant or award : show line 1 in the form | +355,000 | 2,931,701 | D | ||
| 2025-03-05 | Sale : show line 2 in the form | −81,206 | $6.98 | $566,818 | 2,850,495 | D |
| 2025-03-05 | Sale : show line 3 in the form | −36,145 | $6.99 | $252,654 | 2,814,350 | D |
| 2025-03-05 | Grant or award : show line 4 in the form | +247,117 | 3,061,467 | D | ||
| 2025-03-06 | Sale : show line 5 in the form | −102,218 | $7.64 | $780,946 | 2,959,249 | D |
| Open-market sales · 219,569 sh · avg $7.29 · $1,600,417 | ||||||
Loading xslF345X05/form4.xml…